Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose esomeprazole + bismuth + amoxicillin versus standard bismuth-based quadruple therapy for Helicobacter pylori eradication
IRCT20251001067450N1Phase 4Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esomeprazole, bismuth subsalicylate and amoxicillin in Helicobacter pylori infection (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Nov 2025; status: completed.
02
Drugs
esomeprazolebismuth subsalicylateamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT20251001067450N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251001067450N1.